BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31602254)

  • 1. Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma.
    Zhou L; Jia S; Ding G; Zhang M; Yu W; Wu Z; Cao L
    J Cancer; 2019; 10(21):5031-5040. PubMed ID: 31602254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distinct role of CD73 in the progression of pancreatic cancer.
    Zhou L; Jia S; Chen Y; Wang W; Wu Z; Yu W; Zhang M; Ding G; Cao L
    J Mol Med (Berl); 2019 Jun; 97(6):803-815. PubMed ID: 30927045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance.
    Meng Q; Liang C; Hua J; Zhang B; Liu J; Zhang Y; Wei M; Yu X; Xu J; Shi S
    Theranostics; 2020; 10(9):3967-3979. PubMed ID: 32226532
    [No Abstract]   [Full Text] [Related]  

  • 4. MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
    Xiong G; Huang H; Feng M; Yang G; Zheng S; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):76. PubMed ID: 29615098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.
    Okazaki J; Tanahashi T; Sato Y; Miyoshi J; Nakagawa T; Kimura T; Miyamoto H; Fujino Y; Nakamura F; Takehara M; Ma B; Bando M; Kitamura S; Okamoto K; Muguruma N; Sogabe M; Takayama T
    Digestion; 2020; 101(6):794-806. PubMed ID: 31563901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Oncogenic Targets Controlled by Tumor-Suppressive
    Nepal P; Hozaka Y; Tanaka T; Wada M; Asai S; Minemura C; Idichi T; Arigami T; Kurahara H; Seki N; Ohtsuka T
    Anticancer Res; 2021 Oct; 41(10):4821-4836. PubMed ID: 34593431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
    Wang Y; Qiu C; Lu N; Liu Z; Jin C; Sun C; Bu H; Yu H; Dongol S; Kong B
    Int J Oncol; 2018 Jun; 52(6):2130-2142. PubMed ID: 29620165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
    Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
    Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine enhances OSI-027 cytotoxicity by upregulation of miR-663a in pancreatic ductal adenocarcinoma cells.
    Huang B; Wang J; Chen Q; Qu C; Zhang J; Chen E; Zhang Y; Wang Y; Ni L; Liang T
    Am J Transl Res; 2019; 11(1):473-485. PubMed ID: 30788003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of thymopoietin by miR-139-5p suppresses cell proliferation and induces cell cycle arrest/apoptosis in pancreatic ductal adenocarcinoma.
    Zhou H; Zhang L; Tu H
    Oncol Lett; 2019 Oct; 18(4):3443-3452. PubMed ID: 31516562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-30a-5p promotes cholangiocarcinoma cell proliferation through targeting SOCS3.
    Zhang JW; Wang X; Li GC; Wang D; Han S; Zhang YD; Luo CH; Wang HW; Jiang WJ; Li CX; Li XC
    J Cancer; 2020; 11(12):3604-3614. PubMed ID: 32284757
    [No Abstract]   [Full Text] [Related]  

  • 13. Downregulation of miR-374b-5p promotes chemotherapeutic resistance in pancreatic cancer by upregulating multiple anti-apoptotic proteins.
    Sun D; Wang X; Sui G; Chen S; Yu M; Zhang P
    Int J Oncol; 2018 May; 52(5):1491-1503. PubMed ID: 29568910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
    Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
    PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA NORAD regulates lung cancer cell proliferation, apoptosis, migration, and invasion by the miR-30a-5p/ADAM19 axis.
    Li J; Xu X; Wei C; Liu L; Wang T
    Int J Clin Exp Pathol; 2020; 13(1):1-13. PubMed ID: 32055266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.
    Huang S; Guo H; Cao Y; Xiong J
    Pathol Res Pract; 2019 Apr; 215(4):794-800. PubMed ID: 30683474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1.
    Liu Y; Xia L; Dong L; Wang J; Xiao Q; Yu X; Zhu H
    Cancer Manag Res; 2020; 12():921-929. PubMed ID: 32104074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA CircPVT1 Inhibits 5-Fluorouracil Chemosensitivity by Regulating Ferroptosis Through MiR-30a-5p/FZD3 Axis in Esophageal Cancer Cells.
    Yao W; Wang J; Meng F; Zhu Z; Jia X; Xu L; Zhang Q; Wei L
    Front Oncol; 2021; 11():780938. PubMed ID: 34966683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma.
    Flammang I; Reese M; Yang Z; Eble JA; Dhayat SA
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32630552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin inhibits prostate cancer progression by regulating the miR-30a-5p/PCLAF axis.
    Pan L; Sha J; Lin W; Wang Y; Bian T; Guo J
    Exp Ther Med; 2021 Sep; 22(3):969. PubMed ID: 34335911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.